Stay updated with breaking news from Oliver Nussbaumer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We are delighted to announce that Molten Ventures has led a £11.5 million Series A funding round in IMU Biosciences, a techbio company revolutionising immune powered precision medicine. IMU...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Abingworth, a leading international life sciences investor, announces its portfolio company Adaptate Biotherapeutics ("Adaptate") is to be...
Takeda Pharmaceutical Company Limited “Takeda” this week announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company
/PRNewswire/ -- Abingworth, a leading international life sciences investor, announces its portfolio company GammaDelta Therapeutics is to be acquired by Takeda...